Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers

by Chan Zou, Xiaocong Zuo, Jie Huang, Ye Hua, Shuang Yang, Xiaoyan Yang, Can Guo, Hongyi Tan, Jun Chen, Zhaoxing Chu, Qi Pei, Guoping Yang
Published 2019-10-01

Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients

by Marianna Lucafò, Simona Granata, Erik J. Bonten, Robert McCorkle, Gabriele Stocco, Chiara Caletti, Davide Selvestrel, Alessio Cozzarolo, Chan Zou, Eva Cuzzoni, Andrea Pasini, Giovanni Montini, Giovanni Gambaro, Giuliana Decorti, William Evans, Gianluigi Zaza
Published 2021-05-01